[The role of self-infusion treatment for the patient with haemophilia (author's transl)]
- PMID: 346090
- DOI: 10.1007/BF00996832
[The role of self-infusion treatment for the patient with haemophilia (author's transl)]
Similar articles
-
[Hepatitis in haemophilia (author's transl)].Ther Umsch. 1979 Apr;36(4):322-5. Ther Umsch. 1979. PMID: 377555 Review. German. No abstract available.
-
[New looks in the treatment of haemophilia "A" patients with specific factor VIII inhibitors (author's transl)].Sangre (Barc). 1978;23(1):47-63. Sangre (Barc). 1978. PMID: 345497 Clinical Trial. Spanish. No abstract available.
-
[Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].Med Clin (Barc). 1985 Apr 6;84(13):516-9. Med Clin (Barc). 1985. PMID: 3923278 Spanish. No abstract available.
-
Viral safety of plasma-derived factor VIII and IX concentrates.Blood Coagul Fibrinolysis. 1997 Aug;8 Suppl 1:S19-23. Blood Coagul Fibrinolysis. 1997. PMID: 9351532 Review.
-
[Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)].Ther Umsch. 1979 Apr;36(4):301-6. Ther Umsch. 1979. PMID: 451948 German. No abstract available.
Cited by
-
HTLV III antibodies and immunological alterations in hemophilia patients.Klin Wochenschr. 1986 Feb 3;64(3):115-24. doi: 10.1007/BF01732634. Klin Wochenschr. 1986. PMID: 3005759